文献速递眼底病与葡萄膜炎神经眼科

贝赫切特病眼部表现患者的临床特征与预后评估:聚焦光学相干断层扫描与血管成像

ASSESSMENT OF CLINICAL FEATURES AND PROGNOSIS IN BEHÇET DISEASE PATIENTS WITH OCULAR MANIFESTATIONS: A Focus on Optical Coherence Tomography and Angiography.
PubMed 文献 · Retina · 2025-01-01

这项横断面研究比较了活动性/非活动性眼贝赫切特病、非眼贝赫切特病及健康对照的视网膜微血管结构。非活动性眼贝赫切特病眼中央黄斑厚度较活动性、非眼贝赫切特病及对照显著降低。活动性/非活动性眼贝赫切特病患者深毛细血管丛中心凹无血管区面积和周长显著增大、圆形度指数显著恶化,且与视力下降相关。

要点

  • 非活动性眼贝赫切特病眼中央黄斑厚度显著低于活动性眼贝赫切特病、非眼贝赫切特病及对照眼。
  • 活动性/非活动性眼贝赫切特病患者深毛细血管丛中心凹无血管区面积和周长显著增大、圆形度指数显著恶化。
  • 血管密度和灌注密度在非活动性眼贝赫切特病中较非眼贝赫切特病及对照降低。

核心结论

  • 光学相干断层扫描和光学相干断层扫描血管成像可识别眼贝赫切特病中的视网膜变薄和血管丢失,血管密度、灌注密度和中心凹无血管区指标可作为疾病活动性和视功能的标志物。

研究设计与样本

  • 横断面研究,纳入活动性眼贝赫切特病16眼、非活动性眼贝赫切特病38眼、非眼贝赫切特病20眼及健康对照33眼;疾病活动性基于临床表现和荧光素血管造影判定。

主要发现

  • 非活动性眼贝赫切特病眼中央黄斑厚度为239.9 ± 42.1 µm,活动性眼贝赫切特病为275.3 ± 52.3 µm,非眼贝赫切特病为263.3 ± 22.6 µm,对照为267.6 ± 23.6 µm(P = 0.000)。
  • 内层视网膜厚度也降低(P < 0.05)。
  • 非活动性眼贝赫切特病平均血管密度和灌注密度较非眼贝赫切特病及对照降低(P < 0.05)。
  • 活动性/非活动性眼贝赫切特病患者深毛细血管丛中心凹无血管区面积和周长显著增大、圆形度指数显著恶化,与视力下降相关(P < 0.05)。
  • 最佳矫正视力:活动性眼贝赫切特病为20/32(0.63;0.48 logMAR),非活动性眼贝赫切特病为20/36(0.55;0.41 logMAR),非眼贝赫切特病及对照为20/20(1.00;0.00 logMAR)。

关键数值与推荐

  • 大多数眼贝赫切特病患者在接受稳定的免疫抑制治疗。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To compare retinal microvascular structures in ocular (active/inactive) Behçet disease (OBD) and nonocular Behçet disease (NOB) using optical coherence tomography and optical coherence tomography angiography. METHODS: This cross-sectional study included patients with active/inactive OBD, NOB, and healthy control subjects. Disease activity was based on clinical findings and fluorescein angiography. Optical coherence tomography and optical coherence tomography angiography assessed retinal, choroidal thicknesses, vessel density and perfusion density, and optic nerve head flow, and foveal avascular zone characteristics. The primary aim was to identify retinal and choroidal microvascular alterations to assess their potential as biomarkers for disease activity and progression. RESULTS: Sixteen active OBD, 38 inactive OBD, 20 NOB, and 33 control eyes were analyzed. Most OBD patients were on stable immunosuppressive therapy. Central macular thickness was significantly lower in the inactive OBD eyes (239.9 ± 42.1 µ m) than in active OBD (275.3 ± 52.3 µ m), NOB (263.3 ± 22.6 µ m), and controls (267.6 ± 23.6 µ m) ( P = 0.000). Inner retinal layer thicknesses were also reduced ( P < 0.05). The mean vessel density and perfusion density were decreased in inactive OBD compared with NOB and controls ( P < 0.05). Active/inactive OBD patients demonstrated significantly higher foveal avascular zone areas and perimeters and significant deterioration in the circularity index at the deep capillary plexus, correlating with visual acuity loss ( P < 0.05). Best-corrected visual acuity was 20/32 (0.63; 0.48 logMAR) in active OBD, 20/36 (0.55; 0.41 logMAR) in inactive OBD, and 20/20 (1.00; 0.00 logMAR) in NOB and controls. CONCLUSION: Optical coherence tomography and optical coherence tomography angiography identify retinal thinning and vascular loss in OBD, with vessel density, perfusion density, and foveal avascular zone metrics serving as markers of disease activity and visual function.

来源:Retina,查看原文。版权归原作者所有。

引用

  1. Aygun O, Kadayifcilar S, Karakaya J, et al. ASSESSMENT OF CLINICAL FEATURES AND PROGNOSIS IN BEHÇET DISEASE PATIENTS WITH OCULAR MANIFESTATIONS: A Focus on Optical Coherence Tomography and Angiography. Retina. 2025. PMID: 40694829. doi:10.1097/IAE.0000000000004613

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。